Physician profile
Bo MD He
NPI 1770903320
$2,771.45
in general payments reported to CMS, 2019-2025
10 companies · $620 in 2025
The $620 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $122 · 2021: $130 · 2022: $243 · 2023: $482 · 2024: $677 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,778.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,711.36 | 2020-2025 | Na, Motoband, Motoband Cp |
| Stryker Corporation | $530.86 | 2019-2024 | T2 Alpha, Augment Injectable, Valor |
| Evolution Surgical, INC | $140.78 | 2025 | |
| Skeletal Dynamics INC | $96.78 | 2025 | Implate, Geminus, Align |
| Axogen | $68.31 | 2023 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $68.17 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $66.85 | 2023-2024 | Ankle Fracture, Portfolio |
| Orthopediatrics Corp. | $49.08 | 2019 | |
| Orthofix Medical, INC. | $20.84 | 2023 | Galaxy Fixation System, Galaxy Fixation Gemini, Truelok |
| Medical Device Business Services, INC. | $18.42 | 2024 | Velys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bo He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.